Skip to content
sellWeak cluster of 210b5-1 plan

Catherine Corrigan sold $348k of EXPO

President & CEO at EXPONENT INC. 4,896 shares at an average of $71.09, traded Aug 14, 2025, filed Aug 15, 2025.

Warning score
13
Value
$348k
4,896 shares
Holdings after
82,052
-6% from before
From 52-week low
+3%
low $66.84, close $69.13
From 52-week high
-38%
high $111.60, as of Aug 14, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $348k at market
    +15
  • Share of holdings sold
    Sold 5.8% of holdings
    0
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

EXPOOct 9, 2026 · close 69.81
Since filing Aug 15, 2025: +3.1%SPY +22.6% · excess -19.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000851520-25-000070, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 14, 2025MOption exercise
Common Stock10b5-1
+3,226$25.41$82k84,568Aug 15, 2025
Aug 14, 2025SOpen-market sale
Common Stock10b5-1
-3,226$70.93$229k81,342Aug 15, 2025
Aug 14, 2025MOption exercise
Common Stock10b5-1
+2,380$29.05$69k83,722Aug 15, 2025
Aug 14, 2025SOpen-market sale
Common Stock10b5-1
-1,670$71.38$119k82,052Aug 15, 2025
Aug 14, 2025MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-3,226--29,030Aug 15, 2025
Aug 14, 2025MOption exercise
Non-Qualified Stock Option (right to buy)derivative10b5-1
-2,380--26,178Aug 15, 2025

Related signals

Other insiders at EXPONENT INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
10Weak
EXPObuy
EXPONENT INC
Shukri Jeries Souri
Group Vice President
$13k
184 shares
+0%
3Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$228k
3,225 shares
-4%
5Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$345k
4,900 shares
-6%
5Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$329k
4,930 shares
-6%
5Weak
EXPOsell10b5-1
EXPONENT INC
Catherine Corrigan
President & CEO
$343k
4,905 shares
-6%
53Moderate
EXPOsell 2
EXPONENT INC
Joseph Sala
Group Vice President
$113k
1,595 shares
-100%
60Notable
EXPOsell 3
EXPONENT INC
Joseph Rakow
Group Vice President
$122k
1,573 shares
-100%
41Moderate
EXPOsell 3
EXPONENT INC
John Pye
Group Vice President
$153k
2,000 shares
-6%
62Notable
EXPOsell 3
EXPONENT INC
Bradley A James
Group Vice President
$214k
2,694 shares
-100%
36Weak
EXPOsell
EXPONENT INC
Richard Reiss
Group Vice President
$149k
1,736 shares
-49%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Catherine Corrigan sold $348k of EXPO | InsiderTell